BioNTech (Uzbek Wikipedia)

Analysis of information sources in references of the Wikipedia article "BioNTech" in Uzbek language version.

Last modified: 17:33:21, 17 December 2025 (UTC)

Ref.Un. Ref.Website

Global rank Uzbek rank

1816web.archive.org

1^st place

44reuters.com

38^th place

55^th place

21sec.report

low place

21cnbc.com

303^rd place

336^th place

11thepharmaletter.com

low place

11europa.eu

62^nd place

110^th place

11tass.ru

307^th place

181^st place

11bbc.com

26^th place

34^th place

11mosmedpreparaty.ru

low place

11biontech.de

low place

11pfizer.com

low place

9,197^th place

11cnn.com

36^th place

72^nd place

11fda.gov

470^th place

537^th place

11nypost.com

376^th place

673^rd place

bbc.com (Global: 26^th place; Uzbek: 34^th place)

Gallagher, James. „UK signs deals for 90 million virus vaccine doses“. BBC News (2020-yil 20-iyul). 2020-yil 14-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.

biontech.de (Global: low place; Uzbek: low place)

investors.biontech.de

„Pfizer und BioNTech geben erfolgreiche erste Zwischenanalyse ihres COVID-19-Impfstoffkandidaten in laufender Phase-3-Studie bekannt“ (de). BioNTech (2020-yil 9-noyabr). 2020-yil 9-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 9-noyabr.

cnbc.com (Global: 303^rd place; Uzbek: 336^th place)

Berkeley Lovelace Jr. „Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday“ (en). CNBC (2020-yil 27-iyul). 2020-yil 14-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.

cnn.com (Global: 36^th place; Uzbek: 72^nd place)

edition.cnn.com

Kounang, Nadia. „Pfizer says early analysis shows its Covid-19 vaccine is more than 90% effective“ (en). CNN (2020-yil 9-noyabr). 2020-yil 9-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 9-noyabr.

europa.eu (Global: 62^nd place; Uzbek: 110^th place)

ec.europa.eu

„Press corner“ (en). European Commission — European Commission. 2020-yil 25-avgustda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.

fda.gov (Global: 470^th place; Uzbek: 537^th place)

Office of the Commissioner. Pfizer-BioNTech COVID-19 Vaccine^(ingl.) // FDA. — 2020-12-14. Архивировано 12 dekabr 2020 года.

mosmedpreparaty.ru (Global: low place; Uzbek: low place)

Дмитриев, Р.; Фон Ройсс, Т., Стрельцова, Ю., Губарев, А. „Коронавирус. Вакцины. Pfizer и BioNTech: первая реальная победа над ковидом!“. мРНК-вакцина обеспечила высочайшую эффективность защиты от ковида и готова остановить пандемию коронавируса (ru). Mosmedpreparaty.ru. Мосмедпрепараты (2020-yil 9-noyabr). 2020-yil 12-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 12-noyabr.

nypost.com (Global: 376^th place; Uzbek: 673^rd place)

„COVID-19 vaccine hopes have made these twins $8 billion richer“ (en). NYP Holdings, Inc. (2020-yil 13-noyabr). 2022-yil 9-aprelda asl nusxadan arxivlangan. Qaraldi: 2022-yil 9-aprel.

pfizer.com (Global: low place; Uzbek: 9,197^th place)

„Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study“ (en). Pfizer (2020-yil 9-noyabr). 2020-yil 9-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 9-noyabr.

reuters.com (Global: 38^th place; Uzbek: 55^th place)

Burger, Ludwig. „Temasek-led investor group in $250 million vaccine bet on Germany's BioNTech“. Reuters (2020-yil 29-iyun). 2020-yil 17-oktyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.
„Germany approves trials of COVID-19 vaccine candidate“. Reuters (2020-yil 23-aprel). 2020-yil 28-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.
Smout, Alistair. „Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, Valneva“. Reuters (2020-yil 21-iyul). 2020-yil 29-sentyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.
Banerjee, Michael Erman, Ankur. „U.S. to pay Pfizer, BioNTech 12.95 billion for COVID-19 vaccine“. Reuters (2020-yil 22-iyul). 2020-yil 22-iyulda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.

sec.report (Global: low place; Uzbek: low place)

„Form F-1 Biontech Se — Registration statement for certain foreign private issuers“ (en). Комиссия по ценным бумагам и биржам. 2021-yil 14-fevralda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.

tass.ru (Global: 307^th place; Uzbek: 181^st place)

„BioNTech начнет строительство завода по производству мРНК-вакцин в Африке в 2022 году“. ТАСС. 2021-yil 26-oktyabrda asl nusxadan arxivlangan. Qaraldi: 2021-yil 26-oktyabr.

thepharmaletter.com (Global: low place; Uzbek: low place)

„The Gates Foundation sees BioNTech potential to ʻdramatically reduce global HIV and tuberculosis’“. www.thepharmaletter.com. 2020-yil 14-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.

web.archive.org (Global: 1^st place; Uzbek: 1^st place)

„Form F-1 Biontech Se — Registration statement for certain foreign private issuers“ (en). Комиссия по ценным бумагам и биржам. 2021-yil 14-fevralda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.
„The Gates Foundation sees BioNTech potential to ʻdramatically reduce global HIV and tuberculosis’“. www.thepharmaletter.com. 2020-yil 14-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.
„Press corner“ (en). European Commission — European Commission. 2020-yil 25-avgustda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.
Burger, Ludwig. „Temasek-led investor group in $250 million vaccine bet on Germany's BioNTech“. Reuters (2020-yil 29-iyun). 2020-yil 17-oktyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.
„BioNTech начнет строительство завода по производству мРНК-вакцин в Африке в 2022 году“. ТАСС. 2021-yil 26-oktyabrda asl nusxadan arxivlangan. Qaraldi: 2021-yil 26-oktyabr.
Berkeley Lovelace Jr. „Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday“ (en). CNBC (2020-yil 27-iyul). 2020-yil 14-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.
„Germany approves trials of COVID-19 vaccine candidate“. Reuters (2020-yil 23-aprel). 2020-yil 28-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.
Gallagher, James. „UK signs deals for 90 million virus vaccine doses“. BBC News (2020-yil 20-iyul). 2020-yil 14-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.
Smout, Alistair. „Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, Valneva“. Reuters (2020-yil 21-iyul). 2020-yil 29-sentyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.
Banerjee, Michael Erman, Ankur. „U.S. to pay Pfizer, BioNTech 12.95 billion for COVID-19 vaccine“. Reuters (2020-yil 22-iyul). 2020-yil 22-iyulda asl nusxadan arxivlangan. Qaraldi: 2020-yil 30-sentyabr.
Дмитриев, Р.; Фон Ройсс, Т., Стрельцова, Ю., Губарев, А. „Коронавирус. Вакцины. Pfizer и BioNTech: первая реальная победа над ковидом!“. мРНК-вакцина обеспечила высочайшую эффективность защиты от ковида и готова остановить пандемию коронавируса (ru). Mosmedpreparaty.ru. Мосмедпрепараты (2020-yil 9-noyabr). 2020-yil 12-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 12-noyabr.
„Pfizer und BioNTech geben erfolgreiche erste Zwischenanalyse ihres COVID-19-Impfstoffkandidaten in laufender Phase-3-Studie bekannt“ (de). BioNTech (2020-yil 9-noyabr). 2020-yil 9-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 9-noyabr.
„Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study“ (en). Pfizer (2020-yil 9-noyabr). 2020-yil 9-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 9-noyabr.
Kounang, Nadia. „Pfizer says early analysis shows its Covid-19 vaccine is more than 90% effective“ (en). CNN (2020-yil 9-noyabr). 2020-yil 9-noyabrda asl nusxadan arxivlangan. Qaraldi: 2020-yil 9-noyabr.
Office of the Commissioner. Pfizer-BioNTech COVID-19 Vaccine^(ingl.) // FDA. — 2020-12-14. Архивировано 12 dekabr 2020 года.
„COVID-19 vaccine hopes have made these twins $8 billion richer“ (en). NYP Holdings, Inc. (2020-yil 13-noyabr). 2022-yil 9-aprelda asl nusxadan arxivlangan. Qaraldi: 2022-yil 9-aprel.

BioNTech (Uzbek Wikipedia)

bbc.com (Global: 26th place; Uzbek: 34th place)

biontech.de (Global: low place; Uzbek: low place)

investors.biontech.de

cnbc.com (Global: 303rd place; Uzbek: 336th place)

cnn.com (Global: 36th place; Uzbek: 72nd place)

edition.cnn.com

europa.eu (Global: 62nd place; Uzbek: 110th place)

ec.europa.eu

fda.gov (Global: 470th place; Uzbek: 537th place)

mosmedpreparaty.ru (Global: low place; Uzbek: low place)

nypost.com (Global: 376th place; Uzbek: 673rd place)

pfizer.com (Global: low place; Uzbek: 9,197th place)

reuters.com (Global: 38th place; Uzbek: 55th place)

sec.report (Global: low place; Uzbek: low place)

tass.ru (Global: 307th place; Uzbek: 181st place)

thepharmaletter.com (Global: low place; Uzbek: low place)

web.archive.org (Global: 1st place; Uzbek: 1st place)

bbc.com (Global: 26^th place; Uzbek: 34^th place)

cnbc.com (Global: 303^rd place; Uzbek: 336^th place)

cnn.com (Global: 36^th place; Uzbek: 72^nd place)

europa.eu (Global: 62^nd place; Uzbek: 110^th place)

fda.gov (Global: 470^th place; Uzbek: 537^th place)

nypost.com (Global: 376^th place; Uzbek: 673^rd place)

pfizer.com (Global: low place; Uzbek: 9,197^th place)

reuters.com (Global: 38^th place; Uzbek: 55^th place)

tass.ru (Global: 307^th place; Uzbek: 181^st place)

web.archive.org (Global: 1^st place; Uzbek: 1^st place)